StockData
MediWound Ltd. logo

MediWound Ltd. (MDWD) stock

MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 2/30
$13.61−0.07 (-0.51%)

Close on Nov 18, 2026Market cap $174.69MP/E –Yield –

MediWound operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$25.27M. The highest annual figure on record is $4.49M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$25.27M–
FY2024Dec 31, 2024-$19.40M–
FY2023Dec 31, 2023-$15.29M–
FY2022Dec 31, 2022-$8.35M–
FY2021Dec 31, 2021-$11.22M–
FY2020Dec 31, 2020-$8.84M-296.8%
FY2019Dec 31, 2019$4.49M–
FY2018Dec 31, 2018-$3.96M–
FY2017Dec 31, 2017-$13.69M–
FY2016Dec 31, 2016-$20.16M–
FY2015Dec 31, 2015-$21.23M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.46M–
Q2 FY2025Jun 30, 2025-$5.72M–
Q2 FY2024Jun 30, 2024-$4.48M–
Q2 FY2023Jun 30, 2023-$4.01M-128.7%
Q2 FY2022Jun 30, 2022-$3.67M–
Q2 FY2021Jun 30, 2021-$2.90M–
Q2 FY2020Jun 30, 2020-$2.71M–
Q2 FY2019Jun 30, 2019$13.94M–
Q2 FY2018Jun 30, 2018-$3.29M–
Q2 FY2017Jun 30, 2017-$3.70M–

More MediWound figures

See a number that looks wrong?